Home › Kidney Cancer (Renal Cell Carcinoma) › Connecticut › New Haven
Kidney Cancer (Renal Cell Carcinoma) clinical trials in New Haven, CT
13 studies for Kidney Cancer (Renal Cell Carcinoma) are looking for participants at sites in and around New Haven (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Open-Label Phase 1/2 Study of NEO-811 in Subjects With Locally Advanced or Metastatic Non-Resectable Clear Cell Renal Cell Carcinoma
RecruitingPhase 1
- NEO-811 Connecticut Site, New Haven
A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma
RecruitingPhase 1
- Yale - New Haven Hospital, New Haven
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
RecruitingPhase 1
- Exelixis Clinical Site #62, New Haven
A Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig Alone or in Combination With Other Agents in Participants With Advanced Renal Cell Carcinoma (RCC) (ROSETTA RCC-208)
RecruitingPhase 1/2
- Local Institution - 0117, New Haven
Testing the Safety and Feasibility of Immunotherapy Drugs, Botensilimab and Balstilimab, Before Surgery for Clear Cell Renal Cell Carcinoma, NEO RoBOT Trial
RecruitingPhase 2
- Yale University Cancer Center LAO, New Haven
Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer
RecruitingPhase 3
- Yale University, New Haven
- Smilow Cancer Hospital-Derby Care Center, Derby · 8 mi away
- Smilow Cancer Hospital Care Center - Guilford, Guilford · 13 mi away
Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma
RecruitingPhase 1
- Xencor Investigative Site, New Haven
A Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors
RecruitingPhase 1/2
- Yale University Hospital, New Haven
Investigation of Lymph Node Biology in Kidney Cancer
RecruitingHealthy volunteers welcome
- Yale University, New Haven
Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors
RecruitingPhase 1
- Yale University School of Medicine /ID# 225707, New Haven
A First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their Body
RecruitingPhase 1/2
- Yale School of Medicine, North Haven · 7 mi away
Trial Of Stereotactic Body Radiation Therapy (SBRT) for Oligoprogression on Immune Checkpoint Inhibitors (ICI) in Metastatic Renal Cell Carcinoma
RecruitingPhase 2
- Yale University, New Haven
Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067
RecruitingPhase 1/2
- Yale Cancer Center, New Haven
Kidney Cancer (Renal Cell Carcinoma) trials in other cities
- Houston, TX35 studies
- New York City, NY27 studies
- Dallas, TX23 studies
- Nashville, TN23 studies
- St. Louis, MO23 studies
- Los Angeles, CA20 studies
- Boston, MA16 studies
- Baldwin Park, CA16 studies
- Philadelphia, PA15 studies
- Pittsburgh, PA15 studies
- Queens, NY15 studies
- Jacksonville, FL14 studies
Other studies in New Haven
- Non-Small Cell Lung Cancer41 studies
- Breast Cancer38 studies
- Cancer (all types)33 studies
- Metastatic Cancer23 studies
- Lung Cancer22 studies
- Head and Neck Squamous Cell Carcinoma22 studies
- Ovarian Cancer21 studies
- Colorectal Cancer20 studies
- Prostate Cancer20 studies
- Acute Myeloid Leukemia17 studies
- Alcohol Use Disorder (AUD)17 studies
- Opioid Overdose17 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.